TWST Return on Tangible Equity | Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) Return on Tangible Equity

2026-06-30: Return Tang Equity -38.97%.
2026-03-31: Return Tang Equity -22.58%.
2025-12-31: Return Tang Equity -21.23%.
2025-09-30: Return Tang Equity -20.58%.

Complete source-backed return tang equity history.

Available history: 2017-09-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-38.97%
2026-03-31	-22.58%
2025-12-31	-21.23%
2025-09-30	-20.58%
2025-06-30	-22.28%
2025-03-31	-56.16%
2024-12-31	-55.44%
2024-09-30	-56.05%
2024-06-30	-56.41%
2024-03-31	-45.48%
2023-12-31	-45.63%
2023-09-30	-42.35%
2023-06-30	-40.60%
2023-03-31	-37.90%
2022-12-31	-35.56%
2022-09-30	-33.84%
2022-06-30	-30.87%
2022-03-31	-26.22%
2021-12-31	-34.47%
2021-09-30	-28.16%
2021-06-30	-23.75%
2021-03-31	-20.13%
2020-12-31	-18.41%
2020-09-30	-41.79%
2020-06-30	-42.25%
2020-03-31	-55.78%
2019-12-31	-138.61%
2019-09-30	-71.57%
2019-06-30	-55.24%
2019-03-31	-75.61%
2018-12-31	-56.24%
2018-09-30	35.04%

Annual Return Tang Equity

Date	Return Tang Equity
2025-09-30	-20.58%
2024-09-30	-56.05%
2023-09-30	-42.35%
2022-09-30	-33.84%
2021-09-30	-28.16%
2020-09-30	-41.79%
2019-09-30	-71.57%
2018-09-30	35.04%
2017-09-30	44.47%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78